---
$id: https://graph.org.ai/products/commodity/51151629
$type: Product
source: UNSPSC
code: "51151629"
title: "Cycrimine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cycrimine

**UNSPSC Code**: 51151629
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent and antimuscarinic agent with the molecular formula C19H29NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 543567RFQQ, chemically known as 1-piperidinepropanol, .alpha.-cyclopentyl-.alpha.-phenyl-, hydrochloride but generally known as cycrimine, which bears US NIH Compound Identifier 2911. European Medicines Agency schedules Cycrimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06867MIG. The term CYCRIMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). CYCRIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cycrimine under HS 29333999 and SITC 51574. As of Q4 2014, CYCRIMINE remains the US FDA Preferred Term for this commodity. Cycrimine bears US NLM identifiers UMLS ID C0056835 and NCI Concept Code C65359. SMILES: OC(C1CCCC1)(CCN1CCCCC1)C1CCCCC1.

